Use of an alpha helical apolipoprotein or HDL associating protein adapted to be administered locally to prevent or reduce stenosis or restenosis or to stabilize a plaque

摘要

The use of an alpha helical apolipoprotein or HDL associating protein for the manufacture of a pharmaceutical composition adapted to be administered locally at a site of injury to prevent or reduce stenosis or restenosis or stabilize a plague before or during bypass surgery, surgery to implant grafts or organs or angioplasty.